OF THE five new hepatitis
C treatments on the market,
Gilead’s combination drug Harvoni
(Ledipasvir/Sofosbuvir) has taken
out line honours in a convincing
way with 68.8% share of scripts
dispensed in new initiations to
March 2016, according to a report
from NostraData.
In other data from the research
company, retail pharmacy total
dispensary value is expected to
drop in value for 2016 and 2017
although the value of prescription
only drugs dispensed increased by
3% year on year last month while
the volume was up only 1%.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Mar 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.